Harnessing medtech market alliances, ŌURA sets IPO plans in motion
ŌURA, creator of its namesake smart ring, has confidentially filed paperwork with the US Securities and Exchange Commission (SEC) for a …
Post
-
-
The 2026 MedTech Forum: Europe’s crisis preparedness takes the fore
The onset of the Covid-19 pandemic stretched Europe’s medical device sector to the limit. During this time, the demand for …
-
Sentante’s endovascular robotic surgery platform secures CE mark
Sentante has gained a CE mark for its endovascular robotic surgery platform, priming the device for commercialisation in Europe. The Lithuania-headquartered …
-
BD launches Elyra thulium fiber laser system for kidney stone care
Becton, Dickinson and Company (BD) has launched the Elyra thulium fiber laser (TFL) system in the US, expanding its offerings …
-
Hydrophilic coatings: choice, flexibility and supply chain resilience
Ever since MD&M West in February 2026, HydroMark™ has gained significant attention within the hydrophilic coating community. However, Formacoat’s Vice …
-
Medtech clinical trials navigate macro trends and regulatory changes
An upcoming conference will investigate the latest trends in the medical devices and medtech clinical trials industry with a focus …
-
Adagio Medical seeks FDA PMA for ventricular ablation system
Adagio Medical has submitted a premarket approval (PMA) application to the US Food and Drug Administration (FDA) for its vCLAS …
-
Podcast: Flexible instruments for minimally invasive treatment – what OEMs need to know
The interest in the healthcare industry for flexible instruments is growing fast. By 2033, GlobalData anticipates the minimally invasive devices …
-
Neurosoft Bioelectronics raises $7.5m to progress BCI development
Neurosoft Bioelectronics has raised $7.5m to advance the development of its brain-computer interface (BCI). The Swiss company’s oversubscribed seed financing round …
-
CDMOS as Strategic Enablers for Device Industrialisation
Global challenges such as navigating an increasingly complicated regulatory landscape, an overall global lack of manufacturing capacities, and high levels …
-
Medtronic to acquire SPR Therapeutics for $650m
Medtronic is to acquire SPR Therapeutics for an upfront cash payment of nearly $650m, expanding care options for individuals with …
-
Jupiter Endovascular’s pulmonary embolectomy system hits primary endpoints in trial
Jupiter Endovascular has shared positive pivotal trial results for its Vertex pulmonary embolectomy system in treating pulmonary embolism (PE). The 123-patient …
-
Podcast: Supply chains, obesity drugs, and patents dominate Q1 earnings trends
With pharma and medtech Q1 earnings season now at a close, some sector areas performed better than others. In this episode, …
-
OncoSil Medical secures TGA approval for pancreatic cancer device
OncoSil Medical has secured the Australian Therapeutic Goods Administration (TGA) approval for its OncoSil device, permitting its use in the …
-
FDA approves Guardant Health’s next-generation liquid biopsy panel
Guardant Health has secured US Food and Drug Administration (FDA) approval for its next generation liquid biopsy panel for informing …
